Exxat has filed a notice of an exempt offering of securities to raise $45,000,202.00 in New Funding.
According to filings with the U.S. Securities and Exchange Commission, Exxat is raising up to $45,000,202.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
About Exxat
Exxat is “the” leading provider of all-in-one education management solutions for programs with clinical or field experiences. Our comprehensive platform streamlines critical processes, including placements, compliance tracking, contract management, and curriculum mapping, to enhance collaboration between schools, sites, and students. With solutions like Exxat Prism, Exxat Approve, and Exxat One, we empower academic institutions and hospital systems to manage every aspect of clinical/field education efficiently. By offering data-driven insights, seamless integration, and real-time communication tools, Exxat supports the training of the next generation of healthcare professionals, ensuring compliance, improving operational efficiency, and fostering meaningful partnerships between educators and clinical sites. Our platform is trusted by 1300+ programs across 550+ academic institutions, 4000+ clinical partners, and supports over 200,000 students nationwide.
To learn more about Exxat, visit https://exxat.com/
Exxat Linkedin Page: https://www.linkedin.com/company/exxat-systems/
Contact:
Aarti Vaishnav, Chief Executive Officer
323-945-8973
https://www.linkedin.com/in/aarti-vaishnav/
SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.
